Babu™ has developed an in silico treatment for COVID-19 with its own signature (​BABU-ONE™)!

Babu's™ CEO & Founder, Steve Liebich, has released today (April 4, 2020) the company's first own-developed (in silico!) cure, not just any cure, but a potential treatment proposal for COVID-19. Working relentlessly and without any break, Steve decided to participate in this cooperative fight against one of the deadliest enemies that our civilization has encountered since the outbreak of the Spanish flu. Only a proposal, this putative treatment can also function as a specific prophylactic tool securing the safety of the most susceptible and the ones put int the highest danger. The treatment is based on oligonucleotide aptamers which have been locked out by big pharmaceutical and biotech companies because of the highly commercialized and money-making antibodies business. This is only the beginning and only time will tell what may happen next. The research proposal is available below. ​

treatment_and_prophylaxis_covid19_steve_liebich_af.pdf
File Size:	1840 kb
File Type:	pdf

Download File

---